Status:

COMPLETED

Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

Aventis Pharmaceuticals

Conditions:

EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT

CHROMOSOME 2q31.2 DELETION SYNDROME

Eligibility:

All Genders

15-65 years

Phase:

PHASE4

Brief Summary

Ehlers-Danlos syndrome vascular type (EDS-IV) is caused by a genetic defect of collagen type III. Patient die (median 40 yrs) of vascular complications. There is no treatment. We showed that arteries ...

Detailed Description

100 patients with verified EDS-IV syndrome are included. Patients are randomized to either celiprolol (50 to 400 mg BID)or no treatment. Patients who are not randomized enter a longitudinal survey of ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Proven disease,
  • No betablocker at inclusion if previous CV event
  • Exclusion criteria:
  • Criteria of not inclusion for the RIGHTEOUS group:
  • Patient having already presented an arterial break or a dissection and treated(handled) by bétâ-blocking(surrounding).
  • Against indication in the use of CELIPROLOL:
  • Unchecked cardiac insufficiency by the treatment
  • cardiogenic shock
  • BAV of 2nd and 3rd not sailed degrees
  • angor of Prinzmetal
  • disease of the sine
  • bradycardia
  • pheochromocytoma untreated
  • low blood pressure
  • sentimentality in the CELIPROLOL
  • Antecedent of anaphylactic reaction
  • myasthenia
  • treatment by FLOCTAFENINE ( Idarac), Sultopride ( interactions ) In these two cases, the patient can be included in the group followed by troop.
  • Criteria of not inclusion for both groups:
  • Refusal to participate in the study.
  • Impossibility to move.
  • Pregnancy
  • Woman in age to procreate without means of effective contraception.

Exclusion

    Key Trial Info

    Start Date :

    October 1 2003

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 1 2011

    Estimated Enrollment :

    54 Patients enrolled

    Trial Details

    Trial ID

    NCT00190411

    Start Date

    October 1 2003

    End Date

    April 1 2011

    Last Update

    January 16 2013

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.